F. Katona

Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.

M. Oelke, F. Haab, P. V. van Kerrebroeck, 2013, European urology.

327 EFFECTS OF TAMSULOSIN OCAS™ AND SOLIFENACIN ON EFFICACY AND QOL PARAMETERS IN MEN WITH LUTS/BPH IN THE SATURN TRIAL

J. Krhut, M. Oelke, P. Kerrebroeck, 2011 .

Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).

M. Oelke, F. Haab, P. V. van Kerrebroeck, 2013, European urology.

MANAGEMENT, ENTERPRISE AND BENCHMARKING

K. Lazányi, A. Mesjasz-Lech, B. Vassileva, 2016 .